0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 1-20 of 492 Articles
Research Letter |  ONLINE FIRST
Michael D. Miedema, MD, MPH; Faye L. Lopez, MS, MPH; Michael J. Blaha, MD, MPH; et al.
JAMA Intern Med. Published online November 17, 2014. doi:10.1001/jamainternmed.2014.6288

Original Investigation |  ONLINE FIRST
Meera Viswanathan, PhD; Leila C. Kahwati, MD, MPH; Carol E. Golin, MD; et al.
JAMA Intern Med. Published online November 17, 2014. doi:10.1001/jamainternmed.2014.5841
Includes: Supplemental Content

Viewpoint |  ONLINE FIRST
Vinay Prasad, MD
JAMA Intern Med. Published online November 10, 2014. doi:10.1001/jamainternmed.2014.5756

Original Investigation |  ONLINE FIRST
Inmaculada Hernandez, PharmD; Seo Hyon Baik, PhD; Antonio Piñera, MD; et al.
JAMA Intern Med. Published online November 03, 2014. doi:10.1001/jamainternmed.2014.5398
Includes: Supplemental Content

Special Communication |  ONLINE FIRST
Daniel J. Morgan, MD, MS; Scott M. Wright, MD; Sanket Dhruva, MD
JAMA Intern Med. Published online November 03, 2014. doi:10.1001/jamainternmed.2014.5444
Includes: Supplemental Content

Viewpoint |  ONLINE FIRST
Mori J. Krantz, MD; Sanjay Kaul, MD
JAMA Intern Med. Published online November 03, 2014. doi:10.1001/jamainternmed.2014.5802

Perspective | 
Vinod E. Nambudiri, MD, MBA
JAMA Intern Med. 2014;174(11):1724-1725. doi:10.1001/jamainternmed.2014.4026.

Invited Commentary | 
Greg A. Sachs, MD
JAMA Intern Med. 2014;174(11):1771-1772. doi:10.1001/jamainternmed.2014.3277.

Research Letter | 
Michael E. Johansen, MD, MS; Timothy R. Huerta, PhD, MS; Caroline R. Richardson, MD
JAMA Intern Med. 2014;174(11):1856-1858. doi:10.1001/jamainternmed.2014.2900.

Original Investigation | 
Jennifer Tjia, MD, MSCE; Becky A. Briesacher, PhD; Daniel Peterson, MA; et al.
JAMA Intern Med. 2014;174(11):1763-1771. doi:10.1001/jamainternmed.2014.4103.
Includes: CME

Original Investigation |  ONLINE FIRST
Seth A. Berkowitz, MD, MPH; Alexis A. Krumme, MS; Jerry Avorn, MD; et al.
JAMA Intern Med. Published online October 27, 2014. doi:10.1001/jamainternmed.2014.5294
Includes: Supplemental Content

Perspective |  ONLINE FIRST
Jonathan McDonagh
JAMA Intern Med. Published online October 27, 2014. doi:10.1001/jamainternmed.2014.5376

Invited Commentary |  ONLINE FIRST
Joshua J. Gagne, PharmD, ScD
JAMA Intern Med. Published online October 20, 2014. doi:10.1001/jamainternmed.2014.3270

Invited Commentary |  ONLINE FIRST
Howard D. Weiss, MD; Gregory M. Pontone, MD
JAMA Intern Med. Published online October 20, 2014. doi:10.1001/jamainternmed.2014.4097

Original Investigation |  ONLINE FIRST
Thomas J. Moore, AB; Joseph Glenmullen, MD; Donald R. Mattison, MD, MS
JAMA Intern Med. Published online October 20, 2014. doi:10.1001/jamainternmed.2014.5262

Invited Commentary |  ONLINE FIRST
Wylie Burke, MD, PhD; Kenneth Thummel, PhD
JAMA Intern Med. Published online October 13, 2014. doi:10.1001/jamainternmed.2014.3276

Original Investigation |  ONLINE FIRST
Bo Wang, PharmD; William J. Canestaro, MSc; Niteesh K. Choudhry, MD, PhD
JAMA Intern Med. Published online October 13, 2014. doi:10.1001/jamainternmed.2014.5266
Includes: Supplemental Content

Invited Commentary |  ONLINE FIRST
Michael Bell, MD
JAMA Intern Med. Published online October 06, 2014. doi:10.1001/jamainternmed.2014.3289

Invited Commentary |  ONLINE FIRST
Jonathan S. Lee, MD; Michael J. Fine, MD, MSc
JAMA Intern Med. Published online October 06, 2014. doi:10.1001/jamainternmed.2014.3996

Research Letter |  ONLINE FIRST
Jeffrey A. Linder, MD, MPH; Jason N. Doctor, PhD; Mark W. Friedberg, MD, MPP; et al.
JAMA Intern Med. Published online October 06, 2014. doi:10.1001/jamainternmed.2014.5225

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
Research Letter  | 
US Food and Drug Administration and Design of Drug Approval Studies
Steven Woloshin, MD, MS; Lisa M. Schwartz, MD, MS; Brittney Frankel, BA; et al.
JAMA Dermatology
Case Report/Case Series  | 
MEK Inhibitor–Induced Dusky Erythema:  Characteristic Drug Hypersensitivity Manifestation in 3 Patients
Urvi Patel, MD; Lynn Cornelius, MD; Milan J. Anadkat, MD
JAMA Dermatology
Original Investigation  | 
Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib
Rena C. Zuo, BA; Andrea B. Apolo, MD; John J. DiGiovanna, MD; et al.
JAMA Neurology
Editorial  | 
Fingolimod and Risk of Varicella-Zoster Virus Infection:  Back to the Future With an Old Infection and a New Drug
Kenneth L. Tyler, MD